Roberto Diletti

Roberto Diletti

Interventional cardiologist / Cardiologist
Erasmus MC - Rotterdam, Netherlands

Latest contributions

CTO ADVANCED Level II: LIVE Educational Cases from Cleveland Clinic London, UK & University Hospital Basel, Switzerland

21 May 2026 – From EuroPCR 2026

This advanced session presents live educational cases on chronic total occlusions (CTO) from leading centers in London and Basel. Participants gain insights into selecting antegrade versus retrograde approaches, interpreting intravascular imaging for informed decision-making, and integrating sophisticated tools and techniques to enhance procedural success in complex...

High definition IVUS-guided treatment strategies in calcified stenoses

20 May 2026 – From EuroPCR 2026

Severely calcified coronary stenoses remain one of the most challenging subsets in contemporary PCI, requiring precise lesion assessment and tailored treatment strategies.

This EuroPCR 2026 session focuses on how high-definition intravascular ultrasound (IVUS) is changing the way these lesions are approached in daily practice.

HD-IVUS enables detailed detection...

High definition IVUS-guided treatment strategies in calcified stenoses

CTO BASIC Level I: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

20 May 2026 – From EuroPCR 2026

This educational session provides a foundational understanding of chronic total occlusions (CTO) through live case presentations from leading centers in Paris and Basel. It covers CTO pathophysiology, angiographic analysis, and essential technical skills including guide catheter support, wire escalation, and microcatheter use. The session aims to...

Evidence for new devices in management of coronary artery disease

19 May 2026 – From EuroPCR 2026

This session reviews the latest evidence on new devices in coronary artery disease management. It covers outcomes from randomized controlled trials including imaging- and physiology-guided PCI with the Bioadaptor device, long-term results of thinner-strut bioresorbable scaffolds, site-specific antithrombotic therapy evaluated in the DESyne BDS Plus Trial,...

IVUS-guided PCI: the path forward

10 Apr 2026

Explore what D. Milasinovic and R. Diletti shared on IVUS-guided PCI.

Calcium and complications management in bifurcation

22 May 2025 – From EuroPCR 2025

Address calcium-related challenges and complication management in coronary bifurcation PCI. This session reviews the impact of intraprocedural complications during two-stent techniques, procedural success and one-year outcomes of intravascular lithotripsy in calcific bifurcations and unprotected left main PCI, and bench-test analyses of perforation management. Additionally, it compares...

Calcium and complications management in bifurcation

More on long-term responsiveness and effectiveness of renal denervation

21 May 2025 – From EuroPCR 2025

This session presents comprehensive data on the long-term responsiveness and effectiveness of renal denervation. Topics include outcomes in patients with chronic kidney disease, arterial stiffness correlations, safety profiles over nine years, and economic evaluations across European healthcare systems.

More on long-term responsiveness and effectiveness of renal denervation

How to avoid and manage complications in CTO interventions

21 May 2025 – From EuroPCR 2025

Learn how to anticipate, prevent, and manage complications during complex CTO interventions. This session presents real-world cases including donor artery dissection, main and distal vessel perforations, and the importance of teamwork in the cath lab for successful complication management.

How to avoid and manage complications in CTO interventions

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

20 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session on managing calcified coronary stenoses, featuring a recorded live case, two focused lectures, and expert faculty insights. Learn why intravascular ultrasound (IVUS) is essential for assessing lesion severity and morphology, discover how selecting the right calcium modification tools drives procedural success...

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

PCI to treat the bystander disease in STEMI patients: who, when and how?

16 May 2024 – From EuroPCR 2024

Watch this case-based session on PCI for STEMI to see how the guidelines are influenced by the COMPLETE trial. Learn why and how physiology can guide intermediate lesions, the importance of intracoronary imaging guidance, the value of complete revascularization in STEMI patients, the optimal method for...

PCI to treat the bystander disease in STEMI patients: who, when and how?

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence

15 May 2024 – From EuroPCR 2024

In this session, observe the enhanced user-friendliness of IVUS-guided complex PCI with improved AI algorithms, recognize the importance of combining experience with advanced knowledge of tools and techniques for optimal PCI outcomes in heavily calcified stenoses, and understand how tailoring drug-eluting devices for calcified lesions can...

A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence

Antegrade CTO PCI: how to develop a consistent and systematic strategy ?

14 May 2024 – From EuroPCR 2024

This replay provides a comprehensive guide to mastering antegrade wire escalation (AWE), managing failed procedures, and utilizing IVUS to address ambiguous proximal caps. Additionally, learn when to stop in the event of a failed case and explore alternative strategies to ensure optimal patient outcomes.

Antegrade CTO PCI: how to develop a consistent and systematic strategy ?

CTO-PCI in patients with reduced left-ventricular function

18 May 2023 – From EuroPCR 2023

Discover the management strategies for CTO-PCI in patients with reduced left-ventricular function in this session: witness the utilization of ECMO protection during CTO PCI in the presence of electrical instability, encounter the complexities of multivessel PCI in the setting of severe left ventricular systolic dysfunction, explore the...

CTO-PCI in patients with reduced left-ventricular function

How should I treat non-culprit lesions in a patient with STEMI

17 May 2023 – From EuroPCR 2023

You wonder whether complete revascularisation for STEMI patients is beneficial? You want to know how to assess non-culprit lesions? You wonder about the optimal timing for treating non-culprit lesions? You would like to be able to do more for STEMI patients? Then, this session replay is...

How should I treat non-culprit lesions in a patient with STEMI

What is the role of intra-coronary physiology in guiding complete revascularisation?

17 May 2023 – From EuroPCR 2023

Nicola Ryan and Roberto Diletti discuss strategies for complete revascularisation in patients with acute coronary syndrome, and more specifically patients presenting with STEMI and multivessel disease.

What impact does physiology have on the completeness of revascularisation? Should complete revascularisation be guided by physiology? How does it improve performance? In...

What is the role of intra-coronary physiology in guiding complete revascularisation?